Raras
Buscar doenças, sintomas, genes...
Síndrome de braquidactilia-nistagmo-ataxia cerebelar
ORPHA:1246CID-10 · Q87.8OMIM 113400DOENÇA RARA

A síndrome de braquidactilia-nistagmo-ataxia cerebelar é caracterizada por braquidactilia, nistagmo e ataxia cerebelar. Déficit intelectual e estrabismo também são relatados em alguns pacientes.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de braquidactilia-nistagmo-ataxia cerebelar é caracterizada por braquidactilia, nistagmo e ataxia cerebelar. Déficit intelectual e estrabismo também são relatados em alguns pacientes.

Pesquisas ativas
1 ensaio
1 total registrados no ClinicalTrials.gov

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
1
pacientes catalogados
Início
Infancy
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q87.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
2 sintomas
🧠
Neurológico
2 sintomas
🦴
Ossos e articulações
1 sintomas

+ 3 sintomas em outras categorias

Características mais comuns

Braquidactilia
Metacarpo curto
Estrabismo
Nistagmo
Ataxia
Deficiência intelectual
8sintomas
Sem dados (8)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 8 características clínicas mais associadas, ordenadas por frequência.

BraquidactiliaBrachydactyly
Metacarpo curtoShort metacarpal
EstrabismoStrabismus
NistagmoNystagmus
Ataxia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico2026134 papers
Linha do tempo
2026Hoje · 2026🧪 2010Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de braquidactilia-nistagmo-ataxia cerebelar

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

[18F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis.

Annals of clinical and translational neurology2026 Mar 24

To evaluate [18F]fluorodeprenyl-D2 ([18F]F-DED) positron-emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. [18F]F-DED PET was performed in 25 GAD65-AIE patients and 8 controls using dynamic (0-60 min) and static (30-60 min) acquisitions. Global astrogliosis was assessed by volumes of distribution (VT; 1-tissue-compartment model with carotid input) and standardized uptake values (SUV). Regional cerebellar and mesiotemporal (MT) uptake was normalized to global uptake (SUVr). PET measures were correlated with clinical phenotypes, MRI findings, and serum biomarkers (neurofilament light chain [sNfL], GAD65-Ab titers, and glial fibrillary acidic protein [sGFAP]). Clinical phenotypes included limbic encephalitis/temporal lobe epilepsy (LE/TLE; n = 17), stiff-person syndrome (n = 4), and cerebellar ataxia (CA; n = 4), with overlap in nine patients. Global [18F]F-DED uptake was higher in patients than controls. VT analysis showed increased cortical and MT uptake, while SUVr analysis demonstrated elevated MT uptake across the cohort. LE/TLE patients exhibited increased MT uptake, and CA patients showed higher cerebellar uptake. [18F]F-DED uptake did not correlate with sNfL or GAD65-Ab titers, but sGFAP showed associations with cerebellar and white-matter uptake. Regional uptake correlated with clinical severity in LE/TLE (MT lobe) and CA (cerebellar white matter). [18F]F-DED PET reveals region-specific astrogliosis corresponding to clinical manifestations and disease severity in GAD65-AIE, supporting its potential as a monitoring tool for disease activity.

#2

Neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: an important yet overlooked diagnosis in pediatric ataxia.

The Turkish journal of pediatrics2026 Feb 27

Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare, immune-mediated neurological disorder, often associated with neuroblastoma (NB) in children. This study aimed to describe the clinical features, diagnostic challenges, treatment, and outcomes of pediatric patients with NB-associated OMAS. We retrospectively reviewed medical records of seven children diagnosed with NB-associated OMAS between November 1, 2015 and January 31, 2025. Data on demographics, clinical presentation, tumor characteristics, treatment protocols, relapses, and outcomes were collected. The Mitchell-Pike OMS Rating Scale was used to assess severity. The cohort included four girls and three boys, aged 18-36 months (median 31). All had a history of infection and/or vaccination preceding symptom onset. Ataxia was the most common initial symptom (6/7, 85.7%), followed by behavioral disturbances and sleep disorders (5/7, 71.4% each). At presentation, opsoclonus was present in two patients, which was initially misdiagnosed as nystagmus. All but one patient had opsoclonus during the disease course. Neuroblastomas were located in abdominal (n=4), thoracic (n=1), and sacral (n=2) regions; all tumors measured.

#3

Novel PCDH12 pathogenic missense variants cause neurodevelopmental disorders with ocular malformation.

medRxiv : the preprint server for health sciences2026 Mar 06

Protocadherin-12 (PCDH12), a cell-adhesion protein belonging to the non-clustered protocadherin family, plays a crucial role in the establishment and regulation of neuronal connections and communication. Bi-allelic loss-of-function (LoF) variants in the PCDH12 gene have been associated with several neurodevelopmental disorders (NDDs) such as diencephalic-mesencephalic junction dysplasia syndrome, cerebral palsy, and cerebellar ataxia, often accompanied by ocular abnormalities. However, genotypes exhibit variable expressivity. Affected individuals sharing the same PCDH12 variant presenting differing phenotypic severities have posed major challenges towards identification of the underlying pathogenic mechanisms. Here, we report three affected individuals from two families, each harbouring non-truncating pathogenic missense variants in PCDH12 . The patients are compound heterozygous, with each individual carrying one extracellular [c.1742T>G (p.Val581Gly) and c.1861_2del/insCA (p.Ile621His)] and one intracellular variant [c.3370C>T (p.Arg1124Cys) and c.3445G>A (p.Asp1149Asn] on each allele. The children present with a range of phenotypes similar to those associated with LoF variants. One child exhibited microcephaly and seizures, while the two siblings displayed developmental delays and severe behavioral disorders. All three children experienced some degree of visual impairment. The missense variants provided new insights into the neurodevelopmental consequences of compromised PCDH12 function by distinguishing the specific consequences associated with dysfunction in the extracellular versus intracellular domains of PCDH12. All identified missense variants are predicted to be deleterious and destabilizing. The expression of PCDH12 in HEK293T and HeLa cells demonstrated that PCDH12 is expressed effectively, regardless of the presence of missense variants. However, the extracellular variants p.Val581Gly and p.Ile621His compromised the stability of PCDH12's homophilic adhesion. Additionally, we found evidence of an interaction between PCDH12 and the extracellular domain of the epilepsy-associated PCDH19 protein. PCDH12 extracellular missense variants also affect PCDH19 stability. Our study provides evidence that PCDH12 mediates both homophilic and heterophilic interactions. Our findings also highlight the importance of stable PCDH12-mediated adhesion, emphasizing the need to further study the functional consequences of PCDH12 missense variants on brain and visual system development.

#4

Characterizing SCN1A -Related Disorders Using Real-World Data Across 681 Patient-Years.

medRxiv : the preprint server for health sciences2026 Mar 02

SCN1A -related disorders are the single most common monogenic cause of epilepsy and represent a major focus of precision medicine efforts. In conjunction with existing prospective studies, the analysis of real-world data obtained during routine clinical care can expand upon the scale and duration of available data and contribute to the development of meaningful outcomes for clinical trials. Here, we leveraged real-world data to delineate the longitudinal disease history of 100 individuals with SCN1A -related disorders using a systematic approach. We mapped a total of 671 unique clinical terms to a standardized framework in monthly increments across 681 patient-years, including 75 terms related to seizure types. Within this cohort, 89 individuals had presumed loss-of-function variants in SCN1A based on variant type and clinical diagnosis, including those with Dravet syndrome ( N = 79) and genetic epilepsy with febrile seizures plus ( N = 10). Ten individuals had a non-Dravet developmental and epileptic encephalopathy caused by gain-of-function variants in SCN1A . By annotating seizure type and frequency in monthly time-bins, we assessed seizure burden. A median of 17 changes in seizure frequency and ten terms referring to seizure type were identified per participant. Myoclonic seizures occurred with high frequency (median >5 daily), whereas hemiclonic, focal impaired consciousness, and bilateral tonic-clonic seizures occurred more rarely (median monthly). Retrospective analysis of developmental histories showed a range of cognitive abilities. Neurodevelopmental differences were observed in 83% (83/100) of individuals, of whom 83% (69/83) demonstrated delayed language skills. Motor coordination impairments, including gait disturbance, ataxia, hypotonia, and imbalance were annotated in 69% (69/100) of participants. EEG findings varied with age; most were reported as normal before nine months of age, after which the prevalence of abnormal interictal findings increased. Individuals with different clinical syndromes had unique medication landscapes, with 554 prescriptions of 37 unique therapies. Changes in treatment coincided with the diagnosis of an SCN1A -related disorder, with an increase in cannabidiol, clobazam, and fenfluramine and reduction in sodium channel-blocker use following genetic diagnosis. In summary, we reconstructed the longitudinal disease history of SCN1A -related disorders from electronic medical records using a standardized framework for the analysis of real-world clinical data. We refine existing natural history data of SCN1A -related disorders by providing a granular landscape of seizures, comorbidities, and treatment approaches over time.

#5

Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists.

Brain &amp; development2026 Mar 20

Angelman syndrome (AS), a rare neurogenetic disorder affecting approximately 1 in 15,000 live births, results from loss of functional UBE3A gene expression and manifests with severe developmental delay, intellectual disability, absent speech, ataxia, epilepsy, and distinctive behavioral features. Until recently, only symptomatic management was available. This review provides pediatric neurologists with a comprehensive, practice-oriented overview of emerging disease-modifying therapies for AS, focusing on therapeutic approaches advancing through clinical development. The molecular pathophysiology of AS, natural history considerations critical for trial interpretation, and the current evidence for antisense oligonucleotide (ASO) therapies (ION582, GTX-102/apazunersen, rugonersen), gene replacement approaches (MVX-220), and next-generation strategies including CRISPR-based gene editing, artificial transcription factors, small molecules, and novel delivery platforms are reviewed. ASO therapies targeting the UBE3A antisense transcript represent the most clinically advanced approach, with three candidates showing proof-of-concept efficacy in Phase 1/2 studies and two advancing to pivotal Phase 3 trials. Gene replacement therapy offers potential single-administration treatment but faces challenges regarding safety, immune responses, and durability. Next-generation approaches including CRISPR activation, epigenetic editing, and blood-brain barrier-penetrating delivery systems show preclinical promise. Critical challenges include outcome measurement limitations, genotype stratification, long-term safety monitoring, and ensuring equitable access. These advances herald a transformation in AS clinical care and represent a milestone in precision pediatric neurology.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

Integrative genomics reveal genetic links of chronic cough with risk factors and brain regional volumes.

ERJ open research
2026

Structure-based medical acupuncture for trigeminal neuralgia secondary to lateral medullary syndrome: a case report.

Journal of medical case reports
2026

[18F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis.

Annals of clinical and translational neurology
2026

Neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: an important yet overlooked diagnosis in pediatric ataxia.

The Turkish journal of pediatrics
2026

Spectrum of Movement Disorders in Hematological Malignancies: A Comprehensive Systematic Review of Clinical Phenotypes, Mechanisms, and Outcomes.

Tremor and other hyperkinetic movements (New York, N.Y.)
2026

Novel PCDH12 pathogenic missense variants cause neurodevelopmental disorders with ocular malformation.

medRxiv : the preprint server for health sciences
2026

Characterizing SCN1A -Related Disorders Using Real-World Data Across 681 Patient-Years.

medRxiv : the preprint server for health sciences
2026

Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists.

Brain &amp; development
2026

Atypical Clinical Course of Griscelli Syndrome Type 2 With Primarily Neurologic Presentation and Adult-Onset in a 46-Year-Old Male.

American journal of medical genetics. Part A
2026

Richard Gatti: From concert pianist to bone marrow transplants and the DNA damage response syndrome, ataxia-telangiectasia.

DNA repair
2026

Childhood-Onset Huntington's Disease-Like Presentation of SCA17 with Intermediate Repeats, A Case Report.

Cerebellum (London, England)
2026

An Autopsy Case With Fragile X-Associated Tremor/Ataxia Syndrome Presenting Intranuclear Inclusion Bodies Mainly in the Limbic System.

Neuropathology : official journal of the Japanese Society of Neuropathology
2026

Targeted neurological screening for RFC1-related disease in unexplained chronic cough.

Journal of neurology
2026

Case Report: Anti-GT1a antibody-associated ocular flutter.

Frontiers in immunology
2026

Rethinking Corticosteroid Therapy in Pediatric Neurology.

Journal of inflammation research
2026

[Correlation study between tumor location and pathological subtypes of neuroblastic tumors associated with opsoclonus myoclonus ataxia syndrome].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2026

Surgical management of pediatric pineal region tumors: an overview of current strategies.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

Clinical, practical, and psychosocial challenges of living with glucose transporter type 1 deficiency syndrome.

Seizure
2026

Biallelic Novel SKOR2 Variants in Individuals With Cerebellar Hypoplasia and Intellectual Disability, Expanding the Phenotypic Spectrum of Valence-Farazi Cerebellar Ataxia Syndrome.

American journal of medical genetics. Part A
2026

Distinct Risk Profiles in Posterior vs Anterior Circulation Strokes: A Prospective Study from Western India.

The Journal of the Association of Physicians of India
2026

Progressive Myoclonic Epilepsies - A Pragmatic Review.

Neurology India
2026

Bilateral basal ganglia hyperintensity and cerebellar dysfunction in avermectin poisoning: a case report.

Journal of medical case reports
2026

A case report of persistent cerebellar dysfunction following acute lithium toxicity.

BMC neurology
2026

Characterizing Tumor-Induced Ataxia in a Vestibular Schwannoma Mouse Model.

Journal of visualized experiments : JoVE
2026

Prognostic Significance of DNA Repair Gene mRNA Expression in Early-Stage Breast Cancer: Insights into Clinical Relevance.

Oncology research
2026

Herpes Simplex Virus Encephalitis With Cerebellar Infarction and Cortical Laminar Necrosis.

Cureus
2026

Clinical, Radiological, and Genetic Profile of Patients with FA2H-Associated Neurodegeneration: Eight Cases from India and a Review of the Literature.

Tremor and other hyperkinetic movements (New York, N.Y.)
2026

Differential modulation of haematopoietic and oxidative injury by PARP-1 and ATR kinase inhibition in a murine model of acute irradiation.

PloS one
2026

PRPS1 (p.V42L) Mutation in Arts Syndrome Induces Aberrant Neural Stem Cell Development and Neuronal Senescence-Like Phenotype: Rescue by Nicotinamide Mononucleotide Supplementation.

International journal of stem cells
2026

Successful fresh formulation CD19 CAR-T cell therapy for GAD65 antibody-mediated cerebellar ataxia. A Case Report.

Frontiers in immunology
2026

Two Cases of CLIPPERS-like Syndrome Sharing a Hypomorphic UNC13D Variant.

Journal of clinical immunology
2026

Distal arthrogryposis with impaired proprioception and touch: description of 9 additional cases harbouring novel PIEZO2 variants and literature review.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2026

Vestibular assessment in definite cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (CANVAS): A case of siblings study.

Auris, nasus, larynx
2026

Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report.

Frontiers in immunology
2026

T2-FLAIR hyperintensities in the inferior cerebellar peduncles and their association with clinical symptoms, molecular and MRI markers in male FMR1 premutation carriers.

Frontiers in molecular neuroscience
2026

Targeting Cognitive Dysfunction in Spinocerebellar Ataxia Type 2 Through Digital Cognitive Training.

Cerebellum (London, England)
2026

New Neuroimaging Findings in Enoyl-CoA Hydratase Short-Chain 1 (ECHS1) Deficiency.

Cureus
2026

Cannabidiol inhibits phenytoin clearance and can result in clinical changes: Two cases.

Seizure
2026

Unilateral biportal endoscopic partial cervical laminectomy and facetectomy: An ex vivo study and case report.

Veterinary surgery : VS
2026

Human Herpesvirus 6-Associated Miller-Fisher Syndrome in a 5-Year-Old Child: A Case-Based Narrative Review of Pediatric Cases with Infectious Triggers.

Viruses
2026

Epizootic Haemorrhagic Disease Virus (EHDV) Infection in Red Deer (Cervus elaphus), Fallow Deer (Dama dama) and Mouflon (Ovis orientalis musimon) in South-Eastern Spain: Implications for Wildlife Health and Ruminant Disease Ecology.

Animals : an open access journal from MDPI
2026

The eye as a diagnostic key: the ophthalmologist's role in an atypical case of Miller Fisher Syndrome.

Archivos de la Sociedad Espanola de Oftalmologia
2026

Familial Occurrence of Anti-NF155 Autoimmune Nodopathy in Father and Son: Expanding the Spectrum of IgG4-Related Nodopathies.

Case reports in neurological medicine
2026

Correlation between cerebellar lesion topography and differential diagnosis with clinical presentation in dogs.

Journal of veterinary internal medicine
2025

Emerging Forms of Avian Orthoreovirus Infection in Turkeys in Québec, Canada, Associated with Tenosynovitis, Hepatitis, and Encephalitis (2020-2022).

Avian diseases
2026

BRAT1 gene compound heterozygous mutations causing lethal neonatal rigidity and multifocal seizure syndrome: a case report.

Frontiers in pediatrics
2026

First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia.

Frontiers in immunology
2026

Neuropsychiatric sequelae in sporadic viral encephalitis.

Industrial psychiatry journal
2026

The neural underpinnings of cognitive and postural profile of a young adult with congenital cerebellar athrophy: a longitudinal case report.

Frontiers in neuroscience
2026

Novel Mutations in KCNJ10 Gene Associated With SeSAME Syndrome: Rare Disorder With Possible Common Mutation.

Molecular genetics &amp; genomic medicine
2026

Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L-Amino Acid Decarboxylase Deficiency Using an MR-Compatible Cannula: 48 Weeks of Follow-Up.

Journal of inherited metabolic disease
2026

Generation of the induced pluripotent stem cell line ISMMSi061-A from a patient with ataxia, intention tremor, and hypotonia syndrome, childhood-onset.

Stem cell research
2026

Expanding the phenotypic spectrum of CACNA1A-related developmental and epileptic encephalopathy in adults.

Epileptic disorders : international epilepsy journal with videotape
2026

Rehabilitation challenges and progress in a patient with sensory ataxic Guillain-Barré syndrome: a case report.

Physiotherapy theory and practice
2026

Wernicke Encephalopathy Associated with Malabsorption in Degos Disease.

Journal of investigative medicine high impact case reports
2026

Protective role of PASH-1 in CGG repeat-driven RNA and protein toxicity in FXTAS.

iScience
2026

Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA).

Neurology and therapy
2026

The succinate prodrug NV354 prevents brain lesions and late-stage motor dysfunction in mitochondrial complex I deficiency.

iScience
2026

Prolonged Anti-Zic4 Antibody-Positive Cerebellar Degeneration Following COVID-19 Infection.

Neuropsychopharmacology reports
2026

Pearls & Oy-sters: SCA27B as an Elusive Genetic Cause of Episodic Neurologic Symptoms in Later Adulthood.

Neurology
2026

Case Report and Literature Review of Mycoplasma Pneumoniae Associated Opsoclonus-Myoclonus-Ataxia Syndrome.

Cerebellum (London, England)
2026

A Case of Ganglionopathy Presenting with Hyperkinetic Movements.

Tremor and other hyperkinetic movements (New York, N.Y.)
2026

Cerebral Edema Secondary to Heavy Metal Toxicity From Siddha Medicine: A Case Report and Case-Based Review.

Case reports in neurological medicine
2026

Malignancies in the context of Inborn errors of immunity: an immunologist's view.

Expert review of clinical immunology
2026

Oculomotor abnormalities in patients with cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) reflect midline cerebellar impairment.

Journal of neurology
2026

Clinical Heterogeneity in a Scandinavian FMR1 Premutation Carrier Cohort and Basal Ganglia Atrophy in FXTAS.

Cerebellum (London, England)
2026

Clinical Presentation, Genetics, and Laboratory Testing with Integrated Genetic Analysis of Molecular Mechanisms in Prader-Willi and Angelman Syndromes: A Review.

International journal of molecular sciences
2026

Functional and Epigenomic Consequences of DNMT1 Variants in Inherited Neurological Disorders.

International journal of molecular sciences
2026

Myopathy and ataxia related to impaired mitochondrial function in mevalonate kinase deficiency.

Orphanet journal of rare diseases
2026

Child neurology: Early neuroprotective and immunomodulatory intervention in acute shock with encephalopathy and multiorgan failure: Cytokine-storm encephalopathy-case report.

Brain &amp; development
2026

Duolingo-induced seizures in GAD65 IgG associated autoimmune epilepsy.

Epilepsy &amp; behavior reports
2026

Patient-reported Vision Quality-of-life in Parkinsonian Syndromes and Ataxias and Association with Clinical Oculomotor Findings.

medRxiv : the preprint server for health sciences
2026

CTBP1 In Brain Development: A Novel Variant c.107G>C,p.(R36P) Leads to a Distinct Neurodevelopmental Disorder.

Journal of neurochemistry
2026

The Cerebellar Cognitive-Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal-Recessive Spastic Ataxia of Charlevoix-Saguenay: A Large International Cross-Sectional Study.

Movement disorders : official journal of the Movement Disorder Society
2026

Recurrent Miller Fisher Syndrome: A Case Report.

Clinical practice and cases in emergency medicine
2026

Cerebellar clinical syndromes: the triad and rating scales.

Journal of neurology
2026

Consensus Paper: Models of Cerebellar Functions.

Cerebellum (London, England)
2025

Case Report: Intensive multidisciplinary motor-cognitive rehabilitation treatment in Gerstmann-Sträussler-Scheinker syndrome.

Frontiers in rehabilitation sciences
2026

MSTO1-related mitochondrial myopathy and ataxia syndrome: Case series and literature review.

Neuromuscular disorders : NMD
2026

A Novel Gain-of-Function ITPR1 Variant Associated With a Movement Disorder Characterized by Tremor and Dystonia.

American journal of medical genetics. Part A
2026

Immunotherapy response in microsatellite-stable poorly differentiated thyroid carcinoma with mismatch repair deficiency and high tumor mutational burden.

Archives of endocrinology and metabolism
2026

See One, B1, Treat One: Identifying and Managing Thiamine Deficiency in a Patient With Altered Mental Status.

Cureus
2026

An Apparently Isolated Optic Neuropathy Associated with Biallelic Variants in SLC25A46 Gene Encoding the Mitochondrial Ugo1-Like Protein.

Neuro-ophthalmology (Aeolus Press)
2026

Anti-GM1 antibodies in Bickerstaff's brainstem encephalitis.

BMJ case reports
2026

The apolipoprotein gene: a modulating role on brain volume and cognitive function in carriers of the fragile X premutation.

Neurobiology of disease
2026

Retrospective Patient-Completed Questionnaire Exploring Stimulant Medication Effect on Fatigue, Alertness, Cognitive Symptoms, and Quality of Life in Cerebellar Disorders.

Movement disorders clinical practice
2026

Neurologic Manifestations of Hepatic and Gastrointestinal Disease.

Continuum (Minneapolis, Minn.)
2026

Expanding the Genetic Landscape of ATXN2 Variants: Insights From a Biallelic Trinucleotide Repeat Expansion in an Acadian Family.

Neurology. Genetics
2026

Basilar artery free-floating thrombus.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Novel KIF5A variant in a patient with early-onset levodopa-responsive Parkinson's syndrome.

BMJ case reports
2025

West Nile Virus as a Trigger for Acute Inflammatory Demyelinating Polyneuropathy: Exploring Intravenous Immunoglobulin (IVIG) Efficacy and Disease Variability.

Cureus
2026

A novel de Novo KCNC1 mutation (c.1147 C > T) presenting with epilepsy and ADHD: a case report and literature review.

BMC neurology
2026

Constructing Neurology: Jean-Martin Charcot (1825-1893): A Bicentenary Tribute.

Movement disorders clinical practice
2026

Pentanucleotide guanine-rich WGGGW repeats, including CANVAS AGGGA repeats, form a variety of noncanonical structures.

Nucleic acids research
2026

Non-Huntington's disease chorea: an expanding universe with acquired causes.

Brain : a journal of neurology
2025

Late-onset anti-Yo antibody-positive paraneoplastic cerebellar degeneration: a case report.

Frontiers in surgery
2026

Novel Clinical Insights From a Swedish RFC1 Spectrum Disorder Cohort.

European journal of neurology
2025

Autoimmune cerebellar ataxia with anti-Homer3 antibodies associated with herpesvirus infection: a case report and literature review.

Frontiers in immunology
2026

Anti-GQ1b Antibody Syndrome: A Clinician-Oriented Perspective on Diagnostics, Therapy, and Atypical Phenotypes-With an Illustrative 16-Case Institutional Series.

Journal of clinical medicine
2026

Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review.

International journal of molecular sciences
2026

Biallelic Truncating DNAH14 Variant in Siblings with Neurodevelopmental Disorder and Predominant Ataxia: Clinical Report and Literature Review.

International journal of molecular sciences
2026

Clinical Phenotypes and Prognosis of Anti-mGluR1 Encephalitis: A Single-Center Case Series and Comprehensive Literature Review.

Diagnostics (Basel, Switzerland)
2026

RFC1 Repeat Expansion in Chronic Cough: Findings From the Korean Chronic Cough Registry.

Allergy, asthma &amp; immunology research
2026

The genetics of autosomal recessive ALS: a review of the common forms and their phenotypes.

Amyotrophic lateral sclerosis &amp; frontotemporal degeneration
2026

Dengue-triggered opsoclonus myoclonus ataxia syndrome in an infant.

Tropical doctor
2026

Co-occurrence of Neuroleptic Malignant Syndrome and Silent Syndrome in a Patient With Bipolar Disorder: Clinical Challenges and Long-term Neurological Sequelae.

Cerebellum (London, England)
2026

'Pseudo-ataxic' negative myoclonic status in developmental and epileptic encephalopathy with spike-wave activation in sleep: Utility of ACTH therapy beyond west syndrome.

Epileptic disorders : international epilepsy journal with videotape
2026

Brueghel syndrome: A missing entity. Case report.

Neurologia
2026

Overexpression of bank vole PrP(I109) in mice induces a spontaneous atypical prion disease with sex-dependent onset, early NfL elevation, and universal prion strain permissiveness.

Acta neuropathologica communications
2026

Call for action: misinformation about Tourette syndrome from major media network.

European child &amp; adolescent psychiatry
2025

Rapidly Progressive Cerebellar Syndrome Associated With Anti-Yo Antibodies Following Complete Response to Advanced Ovarian Carcinoma Treated With Olaparib: A Case Report.

Cureus
2026

eVGeMdb: a manually curated database for experimentally validated genetic modifiers of neurodegenerative disorders.

NAR molecular medicine
2026

Expanding the neurological spectrum of HTLV-1 beyond HAM/TSP: a contemporary perspective.

Lancet regional health. Americas
2026

Loss of Drosophila UBE3A phenocopies Piezo dysfunction and drives hyperphagic feeding in Drosophila.

Fly
2025

Severe Anti-CV2/CRMP5, Anti-Hu, and Anti-SOX1 Antibody-Positive Paraneoplastic Neurological Syndrome Associated With Tumor Recurrence During Atezolizumab Therapy.

Cureus
2026

Clinical and Genotypic Spectrum of Twinkle-Related Disorders: Insights From a Multinational Cohort Study.

Neurology
2025

Neurodegeneration Within the Spectrum of Pervasive Developmental Disorders.

Cureus
2026

Paraneoplastic neurologic disorders and neurologic complications of immune checkpoint inhibitors.

Handbook of clinical neurology
2026

Immunotherapies in autoimmune movement disorders and cerebellar ataxia.

Handbook of clinical neurology
2026

A novel CLPP variant in a Pakistani family with Perrault syndrome associated with recurrent fevers.

Clinica chimica acta; international journal of clinical chemistry
2026

Diagnostic Detour: A Case of Opsoclonus-Myoclonus-Ataxia Syndrome Initially Misdiagnosed As Tricyclic Antidepressant Toxicity in a Child.

Cureus
2025

Isolated Vertigo as an Early Sign of Anti-GQ1b-Positive Miller Fisher Syndrome: Expanding the Spectrum.

Cureus
2025

Navigating Diagnostic Dilemmas: Miller Fisher Syndrome in Pregnancy Masquerading As Stroke.

Cureus
2026

A Case of Fragile-X Associated Tremor/Ataxia Syndrome Presenting with Hemichorea and Strabismus.

Movement disorders clinical practice
2026

Progression of fragile X-associated tremor/ataxia syndrome revealed by subtype and stage inference.

Brain communications
2025

Case Report: Creutzfeldt-Jakob disease and diagnosis challenges: case report and evidence synthesis.

F1000Research
2026

Integrative transcriptome-wide association analyses reveal PRKCG-linked GABAergic dysfunction in Fragile X-associated tremor/ataxia syndrome.

Nature communications
2026

MRPS Genes Causing Leukoencephalopathy With Profound Cerebral Folate Deficiency in Adults.

Journal of inherited metabolic disease
2026

SWATH-MS reveals tissue-specific proteomic changes in a Leigh syndrome mouse model.

Molecular genetics and metabolism
2026

Coexisting cerebellar ataxia and Lambert-Eaton myasthenic syndrome without malignancy: insights from a case and systematic literature review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

HLA and T-Cell Receptor Investigations in Idiopathic and Paraneoplastic Opsoclonus-Myoclonus in Children.

Neurology(R) neuroimmunology &amp; neuroinflammation
2026

The Spectrum of Movement Disorders in Children with Genetic Developmental and Epileptic Encephalopathies: A Cross-Sectional Observational Study.

Movement disorders clinical practice
2026

The spectrum of movement disorders in neurosyphilis: A systematic review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Miller Fisher Variant of Guillain-Barré Syndrome Presenting With Dysphagia and Ophthalmoplegia.

Cureus
2025

Effect of Physical Therapy on Vestibular Function in Body Lateropulsion Following Wallenberg Syndrome: A Case Report Using the Modified Clinical Test of Sensory Interaction and Balance.

Cureus
2025

CAPOS and Beyond: ATP1A3 Variants in Pediatric Movement Disorders - Case Reports.

Molecular syndromology
2025

A Dual Approach to Rehabilitation of an autoimmune ataxia : A case study involving the Adult-Onset Opsoclonus-Myoclonus-Ataxia Syndrome.

Archives of rehabilitation research and clinical translation
2025

Overlapping Hepatic and Neurological Toxicity Following Intentional Multidrug Poisoning with Acetaminophen, Metoclopramide, and Metronidazole: A Case Report.

Clinical medicine insights. Case reports
2025

Marinesco-Sjögren Syndrome: A Novel SIL1 Variant with In Silico Analysis and Review of the Literature.

Life (Basel, Switzerland)
2025

Phenotype Correlations of Neurological Manifestations in Wolfram Syndrome: Predictive Modeling in a Spanish Cohort.

Diagnostics (Basel, Switzerland)
2025

Isogenic iPSC-derived CTBP1 mutant neuronal cells exhibit neurodevelopmental defects.

Frontiers in neuroscience
2025

A 10-Year-Old Boy With Ataxia-Telangiectasia: A Rare Case Report From Yemen.

Clinical medicine insights. Case reports
2025

Spinocerebellar ataxia, autosomal recessive type 23 (SCAR23) with compound TDP2 variants: clinical, molecular, and quantitative follow-up.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Gerstmann-Sträussler-Scheinker syndrome neuropathology in a Creutzfeldt-Jakob disease-like phenotype patient caused by a novel 6-OPRI sequence in the PRNP gene.

Revue neurologique
2025

Genetic and Epidemiological Aspects of Louis-Bar Syndrome Transmission: The Impact of Consanguineous Marriages on the Incidence of Hereditary Disorders.

Journal of mother and child
2025

Between the Borders: Balint Syndrome as a Rare Manifestation of Posterior Circulation Stroke.

Cureus
2025

Neurocognition, cerebellar functions and psychiatric features in spinocerebellar ataxia type 34: a case series.

Frontiers in computational neuroscience
2025

Fatigue Limits Motor and Cognitive Improvements after High-intensity Exercise Prior to Balance Training over Telehealth in People with Spinocerebellar Ataxia.

International journal of telerehabilitation
2026

Brain atrophy staging in spinocerebellar ataxia type 3 for clinical prognosis and trial enrichment.

EBioMedicine
2025

[Strongyloides stercoralis: a neglected and latent threat].

Nederlands tijdschrift voor geneeskunde
2025

Autoimmune cerebellopyramidal syndrome as a complex form of autoimmune cerebellar ataxia: a cohort study.

Frontiers in immunology
2025

Clinical and Genetic Profiles of 11 Chinese Patients With Angelman Syndrome.

Genetics research
2026

Microstructural White Matter Alterations in Angelman Syndrome: A Fixel-Based Analysis.

Autism research : official journal of the International Society for Autism Research
2025

Repeat Expansions in a Chilean Cohort with Adult-Onset Cerebellar Ataxia.

Cerebellum (London, England)
2026

Expanding the Early Childhood Manifestations of ITPR1 Heterozygous Variants Beyond Congenital Ataxia and Gillespie Syndrome.

Neurology. Genetics
2025

Clinical Framework for Motor Rehabilitation in Parkinsonism: Integrating Individualized and Syndrome-Specific Approaches.

Brain &amp; NeuroRehabilitation
2025

The cyclic nucleotide binding sites of Swiss-Cheese, the Drosophila orthologue of human PNPLA6, are required for its catalytic function.

bioRxiv : the preprint server for biology
2025

Molecular Repositioning of Celecoxib as a Neurotherapeutic Agent in Fragile X‑Associated Tremor/Ataxia Syndrome (FXTAS).

ACS pharmacology &amp; translational science
2025

Opsoclonus-Myoclonus-Ataxia Syndrome Associated with Coexisting Anti-N-Methyl-D-Aspartate Receptor and Glial Fibrillary Acidic Protein Antibodies.

Movement disorders clinical practice
2025

Prodromal Sleep Disturbances and Polysomnographic Findings in Patients With Creutzfeldt-Jakob Disease.

Brain and behavior
2025

Post-COVID Myoclonus-Ataxia Syndrome: A Case Report of Successful Recovery With Intravenous Immunoglobulin (IVIG) Treatment.

Cureus
2025

LATERAL PONTINE STROKE SYNDROME PRESENTING AS A REPEAT STROKE: A CASE REPORT.

Annals of Ibadan postgraduate medicine
2026

Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids Clinical Manifestations in Children Versus Adults.

Pediatric neurology
2026

An Out-of-Place Etiology: Recognizing FMR1 Premutation in the Memory Clinic.

Annals of clinical and translational neurology
2025

Hydrogen Sulfide Signaling in Neurodegenerative Movement Disorders.

Handbook of experimental pharmacology
2025

TDP-43 suppression of ATP8A2 cryptic splicing implicates phosphatidylserine-driven neuroinflammation in ALS/FTD.

bioRxiv : the preprint server for biology
2026

A Novel Biallelic STN1 Mutation Is Associated With Adult-Onset Multisystemic Involvement: Broadening the Mutational Spectrum in Coats Plus Syndrome.

Clinical genetics
2025

Case Report: developmental delay and intellectual disability linked to a maternally inherited derivative chromosome 3 from a t(3;8) translocation.

Frontiers in genetics
2025

Two-year decline in performance on the Cerebellar Cognitive Affective Syndrome Scale in spinocerebellar ataxias.

Journal of neurology
2025

Antibody Positive Miller-Fisher Syndrome and Acute Motor Sensory Axonal Neuropathy With Respiratory Failure: A Rare Overlap.

Cureus
2025

A Novel SIL1 Variant (p.E342K) Associated with Marinesco-Sjögren Syndrome Impairs Protein Stability and Function.

International journal of molecular sciences
2025

Effect of Aminopyridines on Oculomotor Dysfunction in Anti-GAD Ataxia: A Brief Report.

Cerebellum (London, England)
2025

Post-infectious Cytomegalovirus Rhombencephalitis in an Immunocompetent Adult: A Case Report.

Cureus
2025

Paraneoplastic Lambert-Eaton myasthenic syndrome associated with non-small cell lung cancer: data from the European LEMS registry and systematic review.

Neurological research and practice
2025

Deciphering Spastic Ataxia: Clinical and Genetic Profiles.

Neurology. Genetics
2025

Immune Checkpoint Inhibitor-Induced Miller Fisher Syndrome: A Case of Relapsing Symptoms Requiring a Slow Corticosteroid Taper.

Cureus
2025

The Cerebellar Cognitive Affective Syndrome in Essential Tremor Plus.

Cerebellum (London, England)
2025

Anti-Tr/DNER Antibody-Associated Paraneoplastic Neurological Syndrome Complicated with Warthin Tumor: a Case Report and Literature Review.

Cerebellum (London, England)
2025

Oligodendrocyte Inclusion Pathology in Fragile X-Associated Tremor/Ataxia Syndrome.

Movement disorders : official journal of the Movement Disorder Society
2025

Systematic Phenotyping and Molecular Analysis of the Woozy Mouse: A Preclinical Model of Cerebellar Ataxia.

Molecular neurobiology
2026

Real-world evidence supporting orphan drugs approvals for rare neuromuscular disorders in the European Union and the United States: Review of public assessment reports (2015-2025).

Current opinion in pharmacology
2025

The Cerebellar Neuropsychiatric Rating Scale Version 2: Development and Validation.

Cerebellum (London, England)
2025

A case series of neuro-chikungunya: unmasking the neurotropic potential of chikungunya virus.

BMC infectious diseases
2025

Neuroichthyosis: the interplay between brain and skin.

Practical neurology
2026

Clinical Reasoning: A 50-Year-Old Male Patient With Acute Severe Sensory Deafferentation and Bilateral Ptosis With Rapid Recovery.

Neurology
2025

Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS).

Arquivos de neuro-psiquiatria
2025

A Case of Retinopathy-Sensory Neuropathy Syndrome With a Novel Compound Heterozygous FLVCR1 Variant.

Journal of the peripheral nervous system : JPNS
2025

Immunodeficiency and hemolytic uremic syndrome: a case report.

The Turkish journal of pediatrics
2025

ITPR1 Deletion in a Patient With Sensory Ataxic Neuropathy and Sjögren Syndrome.

Journal of the peripheral nervous system : JPNS
2025

Etiologies of Acute Ataxia in Children: A Systematic Review of 1167 Subjects.

Journal of child neurology
2026

Anti-Yo positive paraneoplastic limbic encephalitis associated with nasopharyngeal carcinoma: A rare case.

Radiology case reports
2025

Nerve ultrasound, neuronopathy and cough predict sensory neuropathy patients with RFC1 expansions.

Brain communications
2025

Beyond Parkinson's Disease: A Narrative Review of Neuromelanin MRI in Neurodegenerative Diseases.

Journal of neuroimaging : official journal of the American Society of Neuroimaging
2026

Experience of bortezomib use in refractory autoimmune neurological disorders.

Multiple sclerosis and related disorders
2025

H263A and SCAN1/H493R mutant TDP1 block TOP1-induced double-strand break repair during gene transcription in quiescent cells and promote cell death.

Cell death &amp; disease
2025

Parry-Romberg syndrome associated with ataxia: description of a patient improved after neurorehabilitation.

European journal of translational myology
2025

[Opsoclonus-myoclonus-ataxia syndrome associated with St Louis virus infection in Argentina].

Medicina
2025

Case Report: Compound heterozygous KCTD7 variants in two siblings presenting with myoclonic epilepsy and ataxia.

Frontiers in neuroscience
2025

Psychomotor and non-motor correlates of cognition in spinocerebellar ataxias Types 1, 2, 3, and 6.

Brain communications
2025

Multi-Center National Study of Genotype-Phenotype Correlation and Clinical Characteristics in Children and Young Adults with Friedreich's Ataxia from Serbia.

Biomedicines

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de braquidactilia-nistagmo-ataxia cerebelar.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de braquidactilia-nistagmo-ataxia cerebelar

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. [18F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis.
    Annals of clinical and translational neurology· 2026· PMID 41876947mais citado
  2. Neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: an important yet overlooked diagnosis in pediatric ataxia.
    The Turkish journal of pediatrics· 2026· PMID 41871563mais citado
  3. Novel PCDH12 pathogenic missense variants cause neurodevelopmental disorders with ocular malformation.
    medRxiv : the preprint server for health sciences· 2026· PMID 41867234mais citado
  4. Characterizing SCN1A -Related Disorders Using Real-World Data Across 681 Patient-Years.
    medRxiv : the preprint server for health sciences· 2026· PMID 41867217mais citado
  5. Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists.
    Brain &amp; development· 2026· PMID 41864145mais citado
  6. Cerebellar clinical syndromes: the triad and rating scales.
    J Neurol· 2026· PMID 41663552recente
  7. CLIPPERS syndrome following papillary thyroid carcinoma.
    BMJ Case Rep· 2025· PMID 40908022recente
  8. A novel homozygous missense DNAJC3 variant in syndromic juvenile-onset diabetes.
    J Pediatr Endocrinol Metab· 2025· PMID 40534546recente
  9. A Review of the Ocular Phenotype and Correlation with Genotype in Poretti-Boltshauser Syndrome.
    Medicina (Kaunas)· 2025· PMID 40428839recente
  10. Overlapping syndrome with concomitant mGluR2-Ab and GFAP-Ab: A case report.
    Clin Immunol· 2025· PMID 40294835recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1246(Orphanet)
  2. OMIM OMIM:113400(OMIM)
  3. MONDO:0007226(MONDO)
  4. GARD:971(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Q16944551(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de braquidactilia-nistagmo-ataxia cerebelar

ORPHA:1246 · MONDO:0007226
Prevalência
<1 / 1 000 000
Casos
1 casos conhecidos
Herança
Unknown
CID-10
Q87.8 · Outras síndromes com malformações congênitas especificadas, não classificadas em outra parte
Ensaios
1 ativos
Início
Infancy
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0344467
Repurposing
1 candidato
tridihexethylacetylcholine receptor antagonist
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades